SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krishna Institute of Medical Sciences Ltd (KIMS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 543308 NSE: KIMS | Hospital & Healthcare Services | Small Cap

Krishna Inst.Medi Share Price

703.55 2.55 (0.36%)
As on 07-May'26 13:33

Krishna Institute of Medical Sciences Ltd (KIMS)

BSE: 543308 NSE: KIMS
Key Metrics
Market Cap
₹28,050 Cr.
P/E Ratio
97.29
Price to Book (P/B)
11.87
Price to Sales (P/S)
17.63
EV/EBITDA
57.07
Return on Capital Employed (ROCE)
16.99%
Current Price
₹703.6
Return on Equity (ROE)
15.02%
Return on Assets (ROA)
10.85%
Operating Profit Margin
30.4%
Net Profit Margin
21.88%
Gross Profit Margin
32.5%
Book Value per Share
₹59.1
Sales Growth (YoY)
13.26%
Sales Growth (3 Years)
6.58%
Operating Profit Growth (1 Year)
15.16%
Operating Profit Growth (3 Years)
1.89%
Net Profit Growth (1 Year)
28.73%
52-Week Low / High
₹576 / 798
Net Profit Growth (3 Years)
2.86%
Dividend Yield
0.00%
Promoter Holding
34.11%
Pledged shares (%)
of Promoter's holding (%)
10.26%

Check Before You Invest

Q.1 Stock return of Krishna Institute of Medical Sciences Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 33.21% based on the current price.
Q.1 Revenue growth of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd revenue growth is 13.3% for FY-2025, which is above its 5-year CAGR of 11.87%, indicating faster growth.
Q.1 Which industry/sub-sector does Krishna Institute of Medical Sciences Ltd belong to?
Krishna Institute of Medical Sciences Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.1 Promoter shareholding and pledge status of Krishna Institute of Medical Sciences Ltd?
Promoters hold 34.11% of the Krishna Institute of Medical Sciences Ltd, with 10.26% of their stake pledged, indicating high pledge risk.
Q.1 Revenue growth of Krishna Institute of Medical Sciences Ltd vs industry peers?
Krishna Institute of Medical Sciences Ltd revenue CAGR is 11.87%, compared to the industry median CAGR of 10.30%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on Krishna Inst.Medi

Based on:

Overall Rating
Login to view analysis.

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Krishna Institute of Medical Sciences stock performance

Key Ratios
mw4me loader

Is Krishna Institute of Medical Sciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Krishna Institute of Medical Sciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 14.6%4.8%6.4%3.9%22.7%29.6%31.2%22.6%17%17%-
Value Creation
Index
0.3NANA-0.71.01.61.30.70.30.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4855366287077909331,1431,1321,2221,3841,591
Sales YoY Gr.-10.5%17.3%12.5%11.8%18.1%22.6%-1%8%13.3%-
Adj EPS 0.7-2.9-3.2-1.23.34.976.35.97.27.2
YoY Gr.--515.9%NANANA49.7%43.4%-9.9%-6.8%21.8%-
BVPS (₹) 7.4-4.8-7.913.516.823.434.440.846.754.259.1
Adj Net
Profit
24.3-72-81.3-43.6121189280253235286289
Cash Flow from Ops. 89.479.794.2109161291284271262294-
Debt/CF from Ops. 2.87.97.11.71.10.40.101.22.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.4%11.9%6.6%13.3%
Adj EPS 29.7%17%0.8%21.8%
BVPS24.7%26.5%16.3%16.2%
Share Price - - 32.8% 9.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
9.7-101.951-28.621.524.724.516.813.514.212.7
Op. Profit
Mgn %
21.610.410.38.126.133.13532.129.930.428
Net Profit
Mgn %
5-13.4-12.9-6.215.420.324.522.319.320.718.1
Debt to
Equity
1-5.2-3.30.40.30.1000.20.3-
Working Cap
Days
86919297886664909912940
Cash Conv.
Cycle
-13-2648-11-6-731418-12

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 7.2 7.5
TTM Sales (₹ Cr.) 1,591 3,627
BVPS (₹) 59.1 58
Reserves (₹ Cr.) 2,283 2,242
P/BV 11.87 12.08
PE 97.29 93.28
From the Market
52 Week Low / High (₹) 575.55 / 798.00
All Time Low / High (₹) 187.61 / 798.00
Market Cap (₹ Cr.) 28,050
Equity (₹ Cr.) 80
Face Value (₹) 2
Industry PE 90.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *16.1016.1015.7815.3512.1312.030.000.003.6610.26
* Pledged shares as % of Promoter's holding (%)

Valuation of Krishna Inst.Medi - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales4855366287077909331,1431,1321,2221,384
Operating Expenses + 380480564650584625745769857963
Manufacturing Costs1544119820349243281285334380
Material Costs119130152167180201250238251275
Employee Cost 7692115127137147174187220236
Other Costs 31217991542183440595272
Operating Profit 105566557206308398363366421
Operating Profit Margin (%) 21.6%10.4%10.3%8.1%26.1%33.0%34.8%32.1%29.9%30.4%
Other Income + 434671027241857
Exceptional Items 00000000011
Interest 36798836241895728
Depreciation 34353841434545455858
Profit Before Tax 38-55-57-13147254371337318403
Tax 141724302566938583100
Profit After Tax 24-72-81-44121189278252235303
PAT Margin (%) 5.0%-13.4%-12.9%-6.2%15.3%20.2%24.4%22.3%19.3%21.9%
Adjusted EPS (₹)0.7-2.9-3.2-1.23.34.97.06.35.97.6
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 261-120-1995046249071,3781,6311,8662,168
Share Capital 70505074747880808080
Reserves 191-170-2494295498301,2981,5511,7862,088
Debt +18820824116114911840322659
Long Term Debt1731982141521476840257577
Short Term Debt1510279250006581
Minority Interest0000000000
Trade Payables63747974788581737994
Others Liabilities 134581669119106103106108130268
Total Liabilities 6467437898579571,2141,5691,8122,3973,189

Fixed Assets

Net Fixed Assets +498504576567559582592612674773
Gross Block6575396486807127758278891,0081,155
Accumulated Depreciation1593572113153193235277334382
CWIP 26400281316292530
Investments 182331801782135428261,0621,226
Inventories11151619221626192226
Trade Receivables627696100997387120149187
Cash Equivalents 789839250180402130
Others Assets 485361835871128178177417
Total Assets 6467437898579571,2141,5691,8122,3973,189

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 898094109161291284271262294
PBT 38-55-57-13147254371337318403
Adjustment 69172188177625526254824
Changes in Working Capital -19-26-16-29-125-17-17-18-43
Tax Paid 1-11-22-25-47-43-96-75-85-90
Cash Flow From Investing Activity + -39-100-52-99-108-317-375-238-569-627
Capex -33-100-45-46-21-72-69-121-320-306
Net Investments -30-000-21256118-1861
Others -30-7-53-87-33-362-235-230-382
Cash Flow From Financing Activity + -6125-42-12-242576-15289339
Net Proceeds from Shares 031088095192000
Net Proceeds from Borrowing 089-29-143-35-102-60-14257365
Interest Paid -34-31-28-21-19-14-4-1-5-43
Dividend Paid 0000000000
Others -26-6316633046-5103617
Net Cash Flow -1050-2280-1518-186

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.76N/AN/A-28.6721.4824.6424.3716.7913.4615.02
ROCE (%)14.56N/AN/A3.922.7229.5731.2422.5817.0116.99
Asset Turnover Ratio0.760.770.820.860.870.860.820.670.580.5
PAT to CFO Conversion(x)3.71N/AN/AN/A1.331.541.021.081.110.97
Working Capital Days
Receivable Days36.4046.905050.604633.7025.6033.4040.1044.30
Inventory Days89.109.209.109.407.506.807.306.206.40
Payable Days185.60191.30183167153.90148121.10117.80110.10114.60

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Krishna Institute of Medical Sciences Ltd FAQs

The current trading price of Krishna Inst.Medi on 07-May-2026 13:33 is ₹703.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-May-2026 the market cap of Krishna Inst.Medi stood at ₹28,049.7 Cr

The latest P/E ratio of Krishna Inst.Medi as of 06-May-2026 is 97.29.

The latest P/B ratio of Krishna Inst.Medi as of 06-May-2026 is 11.87.

The 52-week high of Krishna Inst.Medi is ₹798.0 and the 52-week low is ₹575.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krishna Inst.Medi is ₹1,591 ( Cr.) .

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences (KIMS) is one of India’s largest corporate healthcare groups, with a robust footprint across Telangana, Andhra Pradesh, Maharashtra, Kerala, and Karnataka. Operating under the trusted ‘KIMS Hospitals’ brand, the company delivers integrated, multidisciplinary healthcare services with a focus on tertiary and quaternary care, underscoring its commitment to clinical excellence at an affordable cost.

KIMS manages a network of advanced multi-specialty hospitals. Its comprehensive service offering spans specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, organ transplantation, renal sciences, and mother and child care. The company’s growth and reputation are rooted in its unwavering commitment to delivering accessible, high-quality healthcare and its strong relationships with skilled medical professionals. These pillars have been instrumental in strengthening the KIMS Hospitals brand and enhancing its role as a trusted healthcare provider in the regions it serves.

Business area of the company

The company is primarily engaged in the business of rendering medical and healthcare services. KIMS stands as a trusted name among India’s largest corporate healthcare providers, with a robust footprint across South and West India. Operating under the ‘KIMS Hospitals’ brand, its integrated network offers a comprehensive range of multi-disciplinary services, while prioritising affordable tertiary and quaternary care. With its hospitals equipped to provide world-class clinical expertise in patient care, the company tailors its approaches to the evolving needs of diverse patients, thereby, catering to all lives in need.

Key specialties of the company

A few of key specialties of the company are following:

Cardiac sciences: The company provides a comprehensive range of cardiac services to treat all cardiovascular disorders, ranging from preventive programmes to complicated surgeries, including heart transplants. It provides a range of diagnostic and therapeutic services and also offers sophisticated interventional cardiac procedures such as implanting cardioverter defibrillator. In addition, it has a thoracic and cardiovascular surgery department which performs a large number of cardiac surgeries. By using superior medical equipments, it is also able to provide early detection and management of cardiac disorders for its patients.

Neurosciences: It provides comprehensive care to patients with neurological disorders, including brain, spinal cord and peripheral nerve disorders. Equipped with advanced neuro-imaging and monitoring technology, it offers specialized care for patients with a range of neurological diseases including Alzheimer’s disease and related dementia, Parkinson’s disease and other movement disorders, multiple sclerosis, stroke, amyotrophic lateral sclerosis, neuromuscular diseases, epilepsy and brain tumours.

Oncology: It offers a range of oncology treatments, including medical oncology, surgical oncology and radiation oncology. The medical oncology department at its hospitals undertakes diagnosis, assessment, treatment and management of patients with cancer. Its physicians trained in this specialty aim to provide the best possible outcome for cancer patients and provide counselling for patients and their families. Its medical oncologists discuss treatment options with patients, supervise the therapy and manage any complications of disease and/or treatment that may arise. Its surgical oncology programmes offers modern, multidisciplinary treatment of primary and metastatic tumours which collaborates with experts from different departments, represents a dedicated team of physicians working closely to provide patients with comprehensive care for cancers of the liver, pancreas, abdominal cavity, adrenal gland, soft tissue and breast. The oncologists at its hospitals specialize in providing treatment in the field of prostate gland cancers, ovarian cancers, brain cancers and colon cancers by using latest techniques including ‘True Beam STX’, robotic procedures, radiation oncology procedures and new nuclear medicinal advancements in the detection and treatment of rare types of cancers and malignancies. In the field of radiation oncology, it offers advanced technology for cancer treatment including, intensity modulated and image guided radiation treatment, known as ‘IMRT’ and ‘IGRT’. The image guided radiation therapy delivers painless and precise doses to the tumour, minimising any radiation deposited on the surrounding healthy tissue for improved overall outcomes. At the same time, it also offers other radiation treatments, applied alone or in combination with chemotherapy or surgery.

Orthopaedics: It provides comprehensive care in all major areas of orthopaedics, including sports injuries, spine procedures, reconstructive procedures, arthroscopy, trauma and joint replacement. Its surgeons combine surgical expertise with pioneering clinical and basic research in areas such as stimulation of bone and tissue repair and total joint reconstruction. It also strives to provide the best and timely treatment in the fields of paediatric orthopaedics, common and rare injuries to the neck, spine, hip joints, and spine and disc problems.

Renal sciences: It provides a complete range of consultative, diagnostic and treatment services for patients with kidney diseases. The scope of care encompasses all stages of kidney diseases, from earliest detectable changes in kidney function through end stage kidney diseases. The patient care services provided under this specialty cover all aspects of the clinical discipline including preventive nephrology, acute kidney injury, glomerulonephritis, vasculitis, electrolyte and acid base disorders, hypertension, genetic kidney diseases, renal complications of pregnancy, kidney stone disease, chronic kidney disease, kidney transplantation, haemodialysis, peritoneal dialysis and renal osteodystrophy. It provides primary care to patients with end stage renal disease treated with haemodialysis and it also has a peritoneal dialysis programmes.

Gastric sciences: It provides care services for management of diseases of the digestive, liver and biliary systems in patients. It offers care in both medical and surgical gastroenterology with the help of modern equipment backed by advanced intensive care units. Under this specialty it addresses diseases of the oesophagus, stomach, small intestine, colon and rectum, pancreas, gallbladder, bile ducts and liver and also helps in evaluating early stages of cancer. The functioning of the entire digestive system, both related to the passage of food through the digestive canal to the physiological processes of food digestion, absorption and elimination come under the purview of this specialty.

Organ Transplantation: It provides multidisciplinary care for patients who require organ transplantation, including liver transplants and kidney transplants. Its services range from patient focused outpatient services, endoscopy, gastro-intestinal manometry to treatment of complex and advanced liver and pancreatobiliary diseases. Assessment of donors and recipients is carried out from the perspective of matching profiles. Subsequently a healthy organ is surgically removed from the donor and transplanted into the recipient.

Awards and Accreditations

  • 2008: KIMS Secunderabad received its first ISO 9001-2008 certification from AQA International LLC.
  • 2011: KIMS Secunderabad received its first accreditation from NABH.
  • 2015: KIMS Secunderabad was awarded the ‘Healthcare Excellence Award’ by the Indo Global Healthcare Summit and Expo.
  • 2015: KIMS Secunderabad was awarded ‘Nursing Excellence’ award by AHPI.
  • 2015: KIMS Secunderabad was accredited with ISO 9001:2015 certification.
  • 2017: KIMS Secunderabad was awarded by AHPI as a ‘Patient Friendly Hospital’.
  • 2017: KIMS Secunderabad became laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016.
  • 2017: KIMS Secunderabad was awarded ‘Best Hospital of the Year’ in the multispecialty hospital category in Hyderabad and eight other specialities by Times Healthcare Achievers Awards.
  • 2019: 2019 KIMS Secunderabad received certificate of excellence in the category of ‘Best Super-Speciality Hospital in Telangana’ at the National Quality Excellence Awards, 2019 hosted by Praxis Media Institute.
  • 2019: KIMS Secunderabad was awarded ‘Best Hospital to Work For’ from AHPI Global Conclave.
  • 2019: KIMS Secunderabad was accredited by NABL.
  • 2019: KIMS Nellore was issued a certificate of accreditation by NABH for being compliant with NABH pre-accreditation entry level hospital requirements.
  • 2020: KIMS Secunderabad ranked the third best hospital in Hyderabad by The Week magazine.
  • 2020: KIMS Kondapur was accredited with a certificate of assessment for exhibition of its intent and commitment towards ensuring safety and hygiene at workplace by IRClass Systems and Solutions.
  • 2021: The cardiology, emergency and trauma, nephrology and neuroscience departments of KIMS Hyderabad were ranked first in the Hyderabad Multi Speciality category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.
  • 2021: The emergency and trauma and nephrology departments of KIMS Hyderabad were ranked second in the South Multi Speciality Category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.
  • 2022: KIMS Secunderabad - Ranked 2nd Best Hospital in Hyderabad by The Week magazine.
  • 2022: KIMS Hospital, Gachibowli received its first accreditation from NABH.
  • 2022: KIMS Saveera Hospital, Anantapur received its first accreditation from NABH.
  • 2022: KIMS Hospital, Ongole received its first accreditation from NABH.
  • 2022: KIMS Hospital, Srikakulam received its pre-entry level accreditation from NABH.
  • 2023: KIMS Saveera Hospital, Anantapur has received CSSD - ACE Certification.
  • 2023: AHPI Healthcare Excellence Award in the category of “Excellence in Nursing Practices”.
  • 2023: Appreciation award for conducting pre-conference workshop at KIMS Hospitals by CAHOCON 2023.
  • 2023: Accredited by American Accreditation Commission International (AACI) 2023.
  • 2023: KIMS Hospitals, Secunderabad ranked the Second Best Multispeciality Hospital in Hyderabad by The Week Magazine.
  • 2023: KIMS-Sunshine Hospitals ranked the Sixth Best Multispeciality Hospital in Hyderabad by The Week Magazine.
  • 2023: KIMS-Sunshine Hospitals ranked the Fifth Best Multispeciality Private Hospital in Hyderabad by The Week Magazine.
  • 2023: KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Hospital in Nagpur by The Week Magazine.
  • 2023: KIMS-Kingsway Hospitals ranked the Fourth Best Multispeciality Private Hospital in Nagpur by The Week Magazine.
  • 2023: KIMS Group of Hospitals ranked the Second Large Healthcare Organization in South Region - ACE 2023 Awards.
  • 2024: Best Stroke Rehab Center in South India at the 2nd Stroke Innovations & Excellence Awards 2024.
  • 2024: KIMS Hospitals, Secunderabad - Best BSD Certifying Team in South India by the Ministry of Health and Family Welfare and NOTTO.
  • 2024: KIMS Hospitals, Kondapur - Best Hospital with Remote Monitoring System at the 2024 Financial Express Healthcare Awards.
  • 2024: KIMS Hospitals, Secunderabad - received the AHPI Award 2024 in the category of “Excellence in Nursing Practices”.
  • 2024: KIMS Hospitals, Gachibowli - received the AHPI Award 2024 in the category of “Excellence in Nursing Practices”.
  • 2024: KIMS-Saveera Hospital, Anantapur - received award of 'Excellence in Nursing Practices” by the NABH.
  • 2024: KIMS-Kingsway Hospital, Nagpur - received Digital Health Standards 'Gold Certificate' by NABH.
  • 2025: KIMS Hospitals, Secunderabad - AHPI Healthcare Excellence Award in the category of “Excellence in Hospital Operations (Non-Clinical)”.
  • 2025: KIMS Hospitals, Kurnool - received its first accreditation from NABH.
  • 2025: KIMS Hospitals, Kondapur - AHPI Healthcare Excellence Award in the category of “Excellence in Nursing Practices”.
  • 2025: KIMS Hospitals, Secunderabad - AHPI Healthcare Excellence Award in the category of “Non-Clinical Hospital Operations”.
  • 2025: KIMS-USHALAKSHMI Centre for Breast Diseases received the Guinness World Record for ' Largest Breast Cancer Awareness Lesson '.
  • 2025: KIMS-USHALAKSHMI Centre for Breast Diseases received the Guinness World Record for ' Most Views for a Breast Cancer Awareness Lesson on YouTube in 24 hours'.

Major events and milestones

  • 2000: KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to the Company pursuant to the 2012 Scheme.
  • 2004: KIMS Secunderabad established by Company.
  • 2010: Investment by Milestone Private Equity Fund (“MPEF”) in Company.
  • 2014: Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals.
  • 2015: Investment by India Advantage Fund (IAF) and Emerging India Fund (EIF) and exit of MPEF from the Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF.
  • 2017: Acquisition of KIMS Ongole by way of slump sale agreement.
  • 2019: Acquisition of 51% of the equity shareholding of ICIMSPL.
  • 2019: Acquisition of 80% of the equity shareholding of SIMSPL.
  • 2019: Investment by General Atlantic in the Company and exit of IAF and EIF from the Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF.
  • 2020: Acquisition of 55% of the equity shareholding of KHKPL.
  • 2021: Krishna Institute of Medical Sciences lists with 22% premium on the BSE.
  • 2022: Krishna Institute of Medical enters into MoU to set up Multi-Specialty Hospital in Nashik.
  • 2023: Krishna Institute of Medical gets nod to raise Rs 300 crore through NCDs.
  • 2024: Krishna Institute of Medical enters into lease agreement to set up Super Specialty Hospital in Bengaluru.
  • 2024: Krishna Institute of Medical acquires 100% equity stake in QNRI.
  • 2024: Krishna Institute inks MoU with Wipro GE Healthcare.
  • 2024: Krishna Institute of Medical Sciences inks pact with Insignia Healthcare.
  • 2025: Krishna Institute enters into strategic partnership with UAIMS Hospital, Sangli.
  • 2025: Krishna Institute of Medical Sciences’ wholly owned subsidiary -- KIMS Hospital Bengaluru has formally commenced operations at newly established hospital located in Mahadevapura, Bengaluru.
  • 2025: Krishna Institute of Medical Sciences’ subsidiary -- KIMS Hospital Bengaluru has formally commenced operations at its newly established hospital located at PES University campus in Electronic City, Bengaluru with effect from December 15, 2025.
  • 2026: Krishna Institute sings agreement with Dakshayani Healthcare Services.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×